N-Carbamylglutamate (Carbaglu) In The Treatment Of Hyperammonemia
Phase of Trial: Phase II/III
Latest Information Update: 23 Aug 2016
At a glance
- Drugs Carglumic acid (Primary)
- Indications Hyperammonaemia
- Focus Therapeutic Use
- 11 Dec 2015 Planned End Date changed from 1 Jul 2016 to 1 Jul 2018 as reported by ClinicalTrials.gov record.
- 11 Dec 2015 Planned primary completion date changed from 1 Jul 2015 to 1 Jul 2017 as reported by clinicalTrials.gov record.
- 13 May 2014 New trial record